| Component | Ratio | Pearls |
|---|---|---|
| PRBC | 1 unit | ~300 mL; Hct ~65% |
| FFP | 1 unit | ~250 mL; all coag factors |
| Platelets | 1 unit (apheresis) | = 6 unit random-donor pool |
| PRBC | Hgb < 7 g/dL (or 8 if cardiac) |
| Platelets (most) | < 50,000/μL |
| Platelets (neuro) | < 75-100,000/μL |
| Platelets (prophylactic) | < 10,000/μL |
| FFP | INR > 1.5 with active bleeding |
| Cryoprecipitate | Fibrinogen < 150-200 mg/dL |
Wilson, R. P. (2023). Blood and blood component therapy. In S. Elisha, J. S. Heiner, & J. J. Nagelhout (Eds.), Nurse anesthesia (7th ed., pp. 400-410). Elsevier.
Massive transfusion is classically more than 10 units of packed red cells within 24 hours, with higher mortality when given within 6 hours (Levy, 2022, p. 2045). Balanced resuscitation uses a fixed 1:1:1 ratio of plasma to platelets to red cells to mimic whole blood. The PROPPR trial found no significant 30 day mortality difference between 1:1:1 and 1:1:2 but showed reduced exsanguination, 9.2% versus 14.6% (Levy, 2022, p. 2057).
Stored blood contains citrate, which chelates ionized calcium and can cause hypotension, a prolonged QT, and impaired coagulation (Levy, 2022, p. 2047); give calcium chloride 1 g IV (or calcium gluconate 3 g) for roughly every 4 to 6 units of product (Haglund & Phillips, 2023, p. 926). Other complications include hyperkalemia, hypothermia, dilutional coagulopathy, and TRALI (Levy, 2022, p. 2047).
Levy, J. H. (2022). Physiology and management of massive transfusion. In Stoelting's pharmacology & physiology in anesthetic practice (6th ed., pp. 2042-2065). Wolters Kluwer.